On Tuesday, Shares of Chevron Corporation (NYSE:CVX), lost -1.53% to $105.02.
Chevron Products Company, a Chevron U.S.A. Inc. division, declared that after 39 years of service, James (Jim) McGeehan, Consulting Scientist for Delo® Heavy Duty Engine Oils has elected to retire from Chevron effective June 30, 2015.
Jim began his career with Chevron in 1976 as a Research Engineer in Chevron Research Company. During his tenure, he has served as the Global Manager of Diesel Engine Oil Technology and was responsible for all global heavy-duty engine oil development and coordinating all diesel engine programs for Chevron’s lubricants businesses. He led the team responsible for the successful development of Chevron Delo 400, which is now a global product meeting worldwide requirements. Jim and his extended formulating team were recently honored by the Society of Automotive Engineers (SAE) for an Award for Research on Automotive Lubricants for the best technical paper related to the Adaption of Lubricants, Lubricated Automotive Systems or Components - SAE Paper 2012-01-1709 (published 2012) in April 2014.
Chevron Corporation, through its auxiliaries, engages in the petroleum, chemicals, and power and energy operations worldwide. The company operates in two segments, Upstream and Downstream.
Shares of UnitedHealth Group Inc. (NYSE:UNH), inclined 0.63% to $120.55, during its last trading session.
Vermont is the healthiest state for seniors, rising from fourth place last year, according to the third edition of United Health Foundation’s America’s Health Rankings® Senior Report: A Call to Action for Individuals and Their Communities.
New Hampshire ranks second, improving one spot from last year. Minnesota fell to third after being ranked first for two years in a row, while Hawaii (4) and Utah (5) round out the top five states. Louisiana ranks 50th as the least healthy state for older adults, followed by Mississippi (49), Kentucky (48), Arkansas (47) and Oklahoma (46).
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company’s United Healthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services.
At the end of Tuesday’s trade, Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), gained 2.82% to $16.38.
Sarepta Therapeutics, Inc. (SRPT), a developer of innovative RNA-targeted therapeutics, declared that the Company held a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) regarding its lead product candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy (DMD). Sarepta has agreed with the Agency to initiate a rolling NDA submission and will submit the non-clinical and CMC components of the NDA by the end of this week. As formerly declared, Sarepta plans to submit the final component of the NDA by mid-year 2015.
“We will initiate a rolling NDA submission to facilitate the regulatory review of the NDA,” said Edward Kaye, M.D., Sarepta’s interim chief executive officer and chief medical officer. “The initiation of our NDA submission for eteplirsen marks a noteworthy milestone for the Duchenne community and we look forward to concluding the submission by the middle of the year and to ongoing to work with the Agency towards the aim of providing treatments to patients as quickly as possible.”
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases.
Finally, Dover Corp (NYSE:DOV), ended its last trade with -0.21% loss, and closed at $75.72.
The Board of Directors of Dover (DOV) declared a regular quarterly cash dividend of $0.40 (forty cents) per share, payable on June 15, 2015 to shareholders of record as of May 29, 2015.
Dover Corporation manufactures and sells a range of equipment and components, specialty systems, and support services in the United States. The company operates in four segments: Energy, Engineered Systems, Fluids, and Refrigeration & Food Equipment.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
